SEE-FIM Protocol

A protocol for examining fallopian tubes in gynecologic pathology

SEE-FIM Protocol

The SEE-FIM protocol is a specialized pathological examination technique used primarily in the study of the fallopian tubes, particularly in the context of ovarian cancer research and diagnosis. The protocol is designed to enhance the detection of early serous tubal intraepithelial carcinoma (STIC), which is believed to be a precursor lesion to high-grade serous carcinoma, a common and aggressive form of ovarian cancer.

Diagram illustrating the SEE-FIM protocol

Background

The SEE-FIM protocol was developed in response to the need for more effective methods of identifying early cancerous changes in the fallopian tubes. Traditional examination methods often missed small lesions, which could lead to delayed diagnosis and treatment. The protocol's name, SEE-FIM, stands for "Sectioning and Extensively Examining the FIMbriated end," highlighting its focus on the fimbrial end of the fallopian tube, where early lesions are most likely to occur.

Procedure

The SEE-FIM protocol involves a meticulous dissection and examination process:

• Sectioning: The fallopian tube is sectioned longitudinally to expose the mucosal surface. This allows for a more comprehensive examination of the epithelial lining.
• Extensive Examination: The fimbrial end of the tube is given particular attention, as this is the most common site for the development of STIC lesions. Multiple sections are taken from this area to ensure thorough evaluation.
• Histological Analysis: The sections are then processed and stained for histological examination under a microscope. Pathologists look for atypical cells and other signs of early malignancy.

Significance

The SEE-FIM protocol has significantly improved the detection rates of early-stage lesions in the fallopian tubes. By identifying STIC lesions, pathologists can provide crucial information that influences the management and treatment of patients at risk for ovarian cancer. This protocol is particularly important for women with BRCA1 or BRCA2 mutations, who are at a higher risk for developing ovarian cancer.

Applications

The protocol is widely used in both clinical and research settings. In clinical practice, it aids in the early detection of ovarian cancer, potentially improving patient outcomes. In research, it provides valuable insights into the pathogenesis of ovarian cancer, contributing to the development of preventive strategies and targeted therapies.

Limitations

While the SEE-FIM protocol is a powerful tool, it is not without limitations. The process is labor-intensive and requires significant expertise in pathological examination. Additionally, not all lesions detected by the protocol will progress to cancer, which can complicate clinical decision-making.

Related pages

• Ovarian cancer
• Fallopian tube
• BRCA1
• BRCA2
• Serous carcinoma